Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...

Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with ...

Hundreds of vials of black-market weight loss drugs have been seized from a home and two clinics in West Tennessee.

Georgie Aldous, from Great Yarmouth in Norfolk, lost the weight using Mounjaro—also known as Tirzepatide that was recently ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Treatment with GLP-1RAs was associated with significant improvements in obstructive sleep apnea-related health outcomes.